Average Co-Inventor Count = 5.85
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (14 from 1,778 patents)
14 patents:
1. 11471537 - Oligomer extended insulin-Fc conjugates
2. 10259856 - Protease stabilized acylated insulin analogues
3. 10124039 - FGF21 derivatives and uses thereof
4. 9896496 - Derivative of an insulin analogue
5. 9895417 - FGF21 derivatives and uses thereof
6. 9744213 - FGF21 derivatives and uses thereof
7. 9688737 - Protease stabilized acylated insulin analogues
8. 9655974 - N-terminal modified FGF21 compounds
9. RE46170 - Insulin derivatives
10. 9260503 - Multi-substituted insulins
11. 9045560 - Protease stabilized, acylated insulin analogues
12. 8791236 - Method of acylating a peptide or protein
13. 8691759 - Protease stabilized, acylated insulin analogues
14. 8067362 - Insulin derivatives